Management of seizures in brain tumor patients at the end of life

Journal of Palliative Medicine

Volumn 3, Issue 4, 2000, Pages 465-475

  Krouwer, H G J ^a   Pallagi, J L ^a,b   Graves, N M ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Rhinelander Medical Center   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ATAXIA; BRAIN TUMOR; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DROWSINESS; EPILEPSY; HEALTH CARE QUALITY; HUMAN; HYPERSALIVATION; LEUKOPENIA; LIVER TOXICITY; NEPHRITIS; PHENOMENOLOGY; PRACTICE GUIDELINE; PSYCHOSIS; RESTLESSNESS; REVIEW; SEIZURE; TERMINAL CARE; TERMINALLY ILL PATIENT; THYROID DISEASE; TREATMENT OUTCOME; TREATMENT PLANNING; VERTIGO; VISUAL IMPAIRMENT;

EID: 0034525278     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2000.3.4.465     Document Type: Review

References (36)

1. The prognosis of primary intracerebral tumours presenting with epilepsy: The outcome of medical and surgical management
2. The course of seizure disorders in patients with malignant gliomas
3. Epilepsy in the cancer patient
4. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis
5. Myoclonus
6. Symptom management, rehabilitation strategies, and improved quality of life for patients with brain tumors
7. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors
8. The role of medications in the management of patients with anaplastic gliomas
9. Seizure prophylaxis with phenytoin in patients with brain metastases
10. The use of phenobarbitone in the management of agitation and seizures at the end of life
11. Subcutaneous midazolam infusion in palliative care
12. Pharmacokinetics of rectal drug administration, Part I
13. Practical use of rectal medications in palliative care
14. Decreased phenytoin levels in patients receiving chemotherapy
15. Corticosteroid toxicity in neuro-oncology patients
16. Manipulation of rectal absorption rate of phenytoin in man
17. Relative bioavailability of rectally administered phenobarbital sodium parenteral solution
18. Replacing carbamazepine slow-release tablets with carbamazepine suppositories: A pharmacokinetic and clinical study in children with epilepsy
19. Relative bioavailability of rectally administered carbamazepine suspension in humans
20. Absorption of valproic acid suppositories in human volunteers
21. Bioavailability of rectally administered valproic acid syrup
22. Failure of absorption of gabapentin after rectal administration
23. Rectal absorption of lamotrigine (LTG) chewable dispersible tablets
24. Rectal use of benzodiazepines
25. A comparison of rectal diazepam gel and placebo for acute repetitive seizures
26. Treating repetitive seizures with a rectal diazepam formulation. A randomized study
27. Bioavailability of rectally administered lorazepam
28. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures?
29. Nasal benzodiazepines for management of acute childhood seizures?
30. Subcutaneous infusions for control of cancer symptoms
31. Symptom control in dying
32. Valproate in status epilepticus
33. Rectal administration of sodium valproate in status epilepticus
34. Rectal valproate syrup and status epilepticus
35. Sudden unexpected death in epilepsy (SUDEP): A clinical perspective and a search for risk factors